Written by Dentistry Today Wednesday, 01 December 2010 13:45
SAN DIEGO, Nov. 30, 2010 /PRNewswire/ - Novalar Pharmaceuticals, Inc., a specialty pharmaceutical company focused in dental, today announced that it has donated over $100,000 worth of OraVerse® product to National Children's Oral Health Foundation (NCOHF). The NCOHF Affiliate network is a consortium of more than 60 of America's finest not-for-profit oral health programs dedicated to eliminating pediatric dental disease by offering quality, comprehensive dental services to the underserved children who need them most.
"We are extremely pleased to make this donation and to be collaborating with NCOHF in its efforts to increase access to dental care for pediatric patients," said Donna Janson, President & CEO of Novalar. "Through this donation program, dentists within the network may effectively treat their patients with local anesthetics without the resulting lingering and unnecessary soft-tissue numbness, allowing them to more quickly return to their normal daily activities."